Hailong Zhang

机构：Second Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0003-3316-4290

发表论文 41 篇 · 总被引 806 次 · h-index 15

代表论文

• Gypenosides improve diabetic cardiomyopathy by inhibiting ROS ‐mediated NLRP 3 inflammasome activation (2018 · Journal of Cellular and Molecular Medicine · 被引 172)
• Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome (2020 · Journal of Cellular and Molecular Medicine · 被引 51)
• Overexpression of PSAT1 regulated by G9A sustains cell proliferation in colorectal cancer (2020 · Signal Transduction and Targeted Therapy · 被引 46)
• 1,25(OH)2D3 alleviates DSS-induced ulcerative colitis via inhibiting NLRP3 inflammasome activation (2020 · Journal of Leukocyte Biology · 被引 46)
• 1H NMR metabolic profiling of gastric cancer patients with lymph node metastasis (2018 · Metabolomics · 被引 23)
• Treatment of Ulcerative Colitis by Cationic Liposome Delivered NLRP3 siRNA (2023 · International Journal of Nanomedicine · 被引 21)